Cargando…
Phase I/II trial evaluating carbon ion radiotherapy for the treatment of recurrent rectal cancer: the PANDORA-01 trial
BACKGROUND: Treatment standard for patients with rectal cancer depends on the initial staging and includes surgical resection, radiotherapy as well as chemotherapy. For stage II and III tumors, radiochemotherapy should be performed in addition to surgery, preferentially as preoperative radiochemothe...
Autores principales: | Combs, Stephanie E, Kieser, Meinhard, Habermehl, Daniel, Weitz, Jürgen, Jäger, Dirk, Fossati, Piero, Orrechia, Roberto, Engenhart-Cabillic, Rita, Pötter, Richard, Dosanjh, Manjit, Jäkel, Oliver, Büchler, Markus W, Debus, Jürgen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3342902/ https://www.ncbi.nlm.nih.gov/pubmed/22472035 http://dx.doi.org/10.1186/1471-2407-12-137 |
Ejemplares similares
-
Phase I study evaluating the treatment of patients with locally advanced pancreatic cancer with carbon ion radiotherapy: the PHOENIX-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2013) -
Phase i study evaluating the treatment of patients with hepatocellular carcinoma (HCC) with carbon ion radiotherapy: The PROMETHEUS-01 trial
por: Combs, Stephanie E, et al.
Publicado: (2011) -
Randomized phase II study evaluating a carbon ion boost applied after combined radiochemotherapy with temozolomide versus a proton boost after radiochemotherapy with temozolomide in patients with primary glioblastoma: The CLEOPATRA Trial
por: Combs, Stephanie E, et al.
Publicado: (2010) -
Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond
por: Combs, Stephanie E, et al.
Publicado: (2013) -
Towards clinical evidence in particle therapy: ENLIGHT, PARTNER, ULICE and beyond
por: Combs, Stephanie E., et al.
Publicado: (2013)